Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yingnan, Dai"'
Publikováno v:
Bioengineered, Vol 12, Iss 1, Pp 1826-1837 (2021)
Bioengineered
article-version (VoR) Version of Record
Bioengineered
article-version (VoR) Version of Record
Ivabradine (Iva), a heart rate reducing agent that specifically inhibits the pacemaker I(f) ionic current, has been demonstrated to be cardioprotective in many cardiovascular diseases. Autophagy is an evolutionarily conserved metabolic process that r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ada8f092aa5b064e018c45668ea582e
https://doi.org/10.1080/21655979.2021.1925008
https://doi.org/10.1080/21655979.2021.1925008
Autor:
Tian-shu Yang, Zhao-yan Song, Jing-Xiu Li, Xue-yan Zhang, Yang Li, En-Ze Jin, Xin Li, Yingnan Dai, Ye-Ping Chen, Li Cha, Ling Weng, Xueqi Li, Shujun Yan, Lin Lin, De-Jun Xia, Wei-jun Lv
Publikováno v:
Cardiovascular Innovations and Applications, Vol 5, Iss 1, Pp 27-35 (2020)
Objectives: We sought to determine whether high posttreatment platelet reactivity (HPPR) to a 600 mg loading dose of clopidogrel affects outcomes in Chinese patients with acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce617267ef0931d3220782e5578a96b
https://www.ingentaconnect.com/content/cscript/cvia/2020/00000005/00000001/art00004
https://www.ingentaconnect.com/content/cscript/cvia/2020/00000005/00000001/art00004
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88137 (2014)
Numerous drugs and compounds have been validated as protecting against myocardial ischemia (MI), a leading cause of heart failure; however, synergistic possibilities among them have not been systematically explored. Thus, there appears to be signific
Externí odkaz:
https://doaj.org/article/5d3b75d619794aaca6cf75f36926c542
Publikováno v:
Biochemical and Biophysical Research Communications. 491:1026-1033
This study aimed to investigate the protective effects of long non-coding RNA KCNQ1OT1 against myocardial ischemia/reperfusion (I/R) injury following acute myocardial infarction, as well as its regulatory mechanism. We used the cardiac muscle H9c2 ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce04682a9a2679f5e5fae3cb7779a54b
https://doi.org/10.1016/j.bbrc.2017.08.005
https://doi.org/10.1016/j.bbrc.2017.08.005
Publikováno v:
Mammalian Genome. 28:220-226
In this study, we aimed to investigate the association of four single nucleotide polymorphisms (SNPs) (MTHFR 677 C > T, MTHFR 1298 A > C, MTR 2756 A > G and MTRR 66 A > G), gene–gene interaction and haplotype combination with pulmonary embolism (PE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae46b47c3fc97d3709fa2b498c62f85b
https://doi.org/10.1007/s00335-017-9692-9
https://doi.org/10.1007/s00335-017-9692-9
Publikováno v:
Lipids in Health & Disease. 3/5/2016, Vol. 15, p1-9. 9p. 1 Diagram, 2 Charts, 2 Graphs.
Publikováno v:
Bioscience Reports
To investigate the effects of miR-9 on high glucose (HG)-induced cardiac fibrosis in human cardiac fibroblasts (HCFs), and to establish the mechanism underlying these effects. HCFs were transfected with miR-9 inhibitor or mimic, and then treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dd22da6e0e39e4c32ffc3c99fa75d05
https://pubmed.ncbi.nlm.nih.gov/27756824
https://pubmed.ncbi.nlm.nih.gov/27756824
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 38(3)
Resveratrol, a polyphenol of natural compounds, has beneficial cardiovascular effects, many of which are mediated by nitric oxide (NO). Resveratrol increases intracellular calcium and activates AMP-activated protein kinase (AMPK), all of which could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a0e69c4f7fd9a6b648dea2a5b33ca9
https://pubmed.ncbi.nlm.nih.gov/27018796
https://pubmed.ncbi.nlm.nih.gov/27018796
Publikováno v:
International journal of clinical and experimental medicine. 7(11)
Background: Previous studies have documented that obstructive sleep apnea (OSA) increases the incidence of hypertension, respiratory failure and unexpected post-operative deaths during night in coronary artery bypass grafting (CABG) patients. We hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2539619c196c17565b15039ee9b5df2
https://pubmed.ncbi.nlm.nih.gov/25550946
https://pubmed.ncbi.nlm.nih.gov/25550946
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88137 (2014)
PLoS ONE
PLoS ONE
Numerous drugs and compounds have been validated as protecting against myocardial ischemia (MI), a leading cause of heart failure; however, synergistic possibilities among them have not been systematically explored. Thus, there appears to be signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a0184c294b2063c1ecf815dcbb593c
http://europepmc.org/articles/PMC3914923?pdf=render
http://europepmc.org/articles/PMC3914923?pdf=render